运动能力与体力活动作为心脏康复试验单vs复合终点的应用:原理、用例与样本量计算蓝图方法
该研究提出将运动能力和体力活动组合为复合主要终点(CE),用于平行组随机对照试验(RCT)评估运动为基础的心脏康复(CR)。基于最小可检测变化和最小临床重要变化(运动能力15 W、体力活动10 min/天),CE组合两个二分终点,并利用两项已完成CR试验的数据比较样本量需求。结果显示CE可能增加或减少样本量,取决于基线比例和干预目标。
要点
- CE由运动能力(15 W变化)和体力活动(10 min/天变化)两个二分终点组成。
- 预期10%组间差异且改善临床结局时,CE可能增加样本量达21%或61%。
- 预期10%差异且干预目标为不恶化时,CE可能减少样本量达55%或70%。
核心结论
- 试验者可考虑使用CE以减少样本量需求,但CE也可能增加所需样本量,取决于试验人群的基线比例和干预目标。
研究设计与样本
- 统计探索性研究,比较基于CE与单终点的样本量需求,使用两项已完成CR试验的数据。
主要发现
- 预期10%组间差异且改善临床结局时,CE增加样本量达21%或61%,取决于数据集。
- 预期10%差异且干预目标为不恶化时,CE减少样本量达55%或70%。
关键数值与推荐
- CE基于最小可检测变化和最小临床重要变化:运动能力变化15 W,体力活动变化10 min/天。
- CE组合两个二分终点(达到/未达到)。
- 运动能力通过增量自行车测功评估Pmax,体力活动通过加速度计评估每日中高强度体力活动分钟数。
临床怎么用
- 在未来的运动为基础的心脏康复试验中,可考虑CE作为主要终点以优化样本量。
- 设计时需根据预期基线比例和干预目标(改善或不恶化)评估CE对样本量的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To conceptualize a composite primary endpoint for parallel-group RCTs of exercise-based cardiac rehabilitation (CR) interventions and to explore its application and statistical efficiency. DESIGN: We conducted a statistical exploration of sample size requirements. We combined exercise capacity and physical activity for the composite endpoint (CE), both being directly related to reduced premature mortality in patients with cardiac diseases. Based on smallest detectable and minimal clinically important changes (change in exercise capacity of 15 W and change in physical activity of 10 min/day), the CE combines 2 dichotomous endpoints (achieved/not achieved). To examine statistical efficiency, we compared sample size requirements based on the CE to single endpoints using data from 2 completed CR trials. SETTING: Cardiac rehabilitation phase III. PARTICIPANTS: Patients in cardiac rehabilitation. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE(S): Exercise capacity (Pmax assessed by incremental cycle ergometry) and physical activity (daily minutes of moderate to vigorous physical activity assessed by accelerometry). RESULTS: Expecting, for example, a 10% between-group difference and improvement in the clinical outcome, the CE would increase sample size by up to 21% or 61%, depending on the dataset. When expecting a 10% difference and designing an intervention with the aim of non-deterioration, the CE would allow to reduce the sample size by up to 55% or 70%. CONCLUSIONS: Trialists may consider the utility of the CE for future studies in exercise-based CR to reduce sample size requirements. However, perhaps surprisingly at first, the CE could also lead to an increased sample size needed, depending on the observed baseline proportions in the trial population and the aim of the intervention.
引用
- Carrozzo AE, Cornelissen V, Bathke AC, et al. Applying Exercise Capacity and Physical Activity as Single vs Composite Endpoints for Trials of Cardiac Rehabilitation Interventions: Rationale, Use-case, and a Blueprint Method for Sample Size Calculation. Arch Phys Med Rehabil. 2024. PMID: 38621456. doi:10.1016/j.apmr.2024.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。